Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

37
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

8
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
8

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin 10 related to lymphopenia in lupus.

European journal of internal medicine·2019
Same author

Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.

Journal of viral hepatitis·2018
Same author

Preparation regimen is more important than patient-related factors: a randomized trial comparing a standard bowel preparation before colonoscopy with an individualized approach.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2016
Same author

Risk of osteonecrosis in patients with systemic lupus erythematosus: A nationwide population-based study.

European journal of internal medicine·2016
Same author

Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?

Lupus·2016
Same author

Epidemiology of gingivitis in schoolchildren in Bucharest, Romania: a cross-sectional study.

Journal of periodontal research·2016

Related Experiment Video

Updated: Jul 12, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K

Estradiol in Systemic Lupus Erythematosus.

A M Constantin1, C Baicus1

  • 1"Carold Davila" Unviersity of Medicine and Pharmacy, Department of Internal Medicine, Bucharest, Romania.

Acta Endocrinologica (Bucharest, Romania : 2005)
|November 1, 2023
PubMed
Summary

Estradiol, a key estrogen, influences immune cells and may impact Systemic Lupus Erythematosus (SLE) development. Its altered interaction with regulatory T cells and microRNAs in SLE patients warrants further investigation into its complex role.

Keywords:
EstradiolEstrogenHormonesLupusRegulatory T cellsSystemic lupus erythematosusmiRNAs

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.7K

Related Experiment Videos

Last Updated: Jul 12, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.7K

Area of Science:

  • Immunology
  • Endocrinology
  • Genetics

Background:

  • Systemic Lupus Erythematosus (SLE) disproportionately affects women of reproductive age, suggesting a role for reproductive hormones.
  • Estradiol, a potent estrogen, significantly influences immune system components, including lymphocytes, regulatory T cells (T-regs), and antibody production.

Purpose of the Study:

  • To investigate the role of estradiol in the pathogenesis of Systemic Lupus Erythematosus (SLE).
  • To explore the relationship between estradiol, regulatory T cells (T-regs), and microRNAs (miRNAs) in SLE patients.

Main Methods:

  • Analysis of estradiol's interaction with estrogen receptors (ERs) and its impact on gene expression.
  • Assessment of estradiol's correlation with regulatory T cell populations (CD4+CD25+, FoxP3+).
  • Investigation of estradiol's interaction with microRNAs (miRNAs), specifically hsa-miR-10b-5p, in SLE pathogenesis.

Main Results:

  • Estradiol influences immune cell function via estrogen receptors (ERs).
  • The expansion of regulatory T cells (T-regs) in response to estradiol is diminished in SLE patients compared to healthy females.
  • Certain microRNAs (miRNAs), like hsa-miR-10b-5p, are overexpressed in SLE patients and show increased levels with estrogen exposure.

Conclusions:

  • Estradiol plays a complex role in SLE pathogenesis through its effects on immune cells and gene regulation via miRNAs.
  • Dysregulation of estradiol's interaction with T-regs and miRNAs may contribute to SLE development.
  • Further research is needed to fully elucidate estradiol's multifaceted role in SLE.